Aspire Biopharma Holdings, Inc. (ASBP)
Nasdaq: ASBP · Pharmaceutical Preparations · Estero, FL · filing with the SEC since 2021
Filings
210 filings since 2017 beside 18 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed May 8, 2026.
Filings a yearinsider forms included
72735575745
2026 counts to Nov 13, 2026.
Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Sep 29, 2026.Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Feb 12, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Oct 17, 2025.SEC letters: 25 in the last 36 months, the newest Apr 13, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed Aug 15, 2024.A late-filing notice, Form NT 10-Q, filed May 15, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 9, 2026
8-K items 5.03, 8.01, 9.01
Charter, bylaw or fiscal-year change; Other event · Current report
Sep 8, 2026
Aug 10, 2026
8-K items 1.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Aug 6, 2026
Jun 12, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
May 14, 2026
8-K items 5.03, 9.01
Charter, bylaw or fiscal-year change · Current report
May 11, 2026
Apr 17, 2026
8-K/A items 1.01, 5.03, 9.01
Major agreement signed; Charter, bylaw or fiscal-year change · Current report, amended
Apr 15, 2026
Apr 16, 2026
8-K items 1.01, 5.03, 9.01
Major agreement signed; Charter, bylaw or fiscal-year change · Current report
Apr 15, 2026
Feb 12, 2026
8-K items 1.01, 3.02, 5.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Officer or director change; Investor disclosure (Regulation FD) · Current report
Feb 6, 2026
40 of 210 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.